To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

Endothelin A Receptor Blo… - University of Gothenburg, Sweden Till startsida
To content Read more about how we use cookies on

Endothelin A Receptor Blockade Improves Endothelium-Dependent Relaxation in Obese Woman

Journal article
Authors Kathryn Gradin
B. Persson
Published in Physiological Research
Volume 67
Pages S167-S174
ISSN 0862-8408
Publication year 2018
Published at Institute of Neuroscience and Physiology, Department of Pharmacology
Pages S167-S174
Language en
Keywords Human small arteries, Endothelin, Endothelium, BQ123, Nitric oxide, Women, Obesity, nitric-oxide, essential-hypertension, cardiovascular-disease, vascular, dysfunction, small arteries, atherosclerosis, vasodilatation, women, vasoconstriction, inhibition, Physiology, NG EH, 2012, Pflugers Arch, V459, P995, EFANO TA, 1999, Circulation, V100, P1680
Subject categories Cardiac and Cardiovascular Systems


Hypertension in obesity is associated with increased insulin resistance, vascular mass and body mass index (BMI). The purpose of the study was to visualize endothelin-1 (ET-1) mediated constriction in arteries isolated from subcutaneous adipose tissue from obese hypertensive women previously operated by gastric bypass. Functional studies were conducted in a microvascular myograph. Expressed as percentage of contraction elicited by 124 mM KCI concentration-response curves for ET-1 were shifted leftward in arteries from obese hypertensive patients compared to healthy normotensive subjects. The vasodilator response to the ET-1 antagonist BQ123 (1 mu M) was significantly higher in arteries from obese hypertensive patients (p<0.001). BQ123 induced relaxation was inhibited by NO synthase inhibitor L-NAME (0.1 nM). Preincubation with BQ123 enhanced the relaxation induced by acetylcholine (ACh; 0.1 nM - 0.1 mM) (p<0.001), but not that induced by NO donor sodium nitroprusside (SNP; 0.1 nM - 0.1 mM), in arteries from obese hypertensive patients. The present study show that hypertension yet prevail after gastric bypass surgery and the ETA receptor antagonist BQ123 may be a useful tool in reducing blood pressure in obese hypertensive patients.

Page Manager: Webmaster|Last update: 9/11/2012

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?